Can a daily supplement ease knee arthritis pain?
NCT ID NCT07643662
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test Mobithron Xtra, an oral supplement containing hyaluronic acid, collagen, and Boswellia extract, in 100 adults with knee osteoarthritis. Participants will take it once daily for 3 months while researchers track changes in pain, stiffness, and daily function using standard questionnaires. The goal is to see if this supplement can help manage symptoms without surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Mobithron Xtra (hyaluronic acid, undenatured type II collagen, Boswellia serrata extract)
- What this could lead to
- If it works, this could provide a non-surgical option to ease knee pain and stiffness in osteoarthritis.
- What could go wrong
- This is a small, early observational study with no control group, so results may not prove effectiveness. Participants cannot take common painkillers, which may limit real-world use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS (OA) OF THE KNEE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Medicine
Kuala Lumpur, Kuala Lumpur, 50603, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ear cartilage to the rescue? a tiny biopsy could rebuild knees
- Which knee surgery approach gets you back on your feet faster?
- Can a lotion outperform standard gel for knee pain?
- A digital coach for knee replacement recovery — can it boost satisfaction and exercise?
- Virtual program aims to keep joint replacement patients moving while they wait
- Cheaper collagen injection could rival standard knee OA treatment